Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-110,138
Closed -$4.2M 1113
2024
Q1
$4.2M Sell
110,138
-919
-0.8% -$34.7K 0.01% 596
2023
Q4
$4.13M Buy
111,057
+47,857
+76% +$1.61M 0.01% 596
2023
Q3
$2.15M Sell
63,200
-3,000
-5% -$113K 0.01% 697
2023
Q2
$2.6M Buy
66,200
+3,900
+6% +$141K 0.01% 674
2023
Q1
$2M Sell
62,300
-11,200
-15% -$370K 0.01% 764
2022
Q4
$2.29M Buy
73,500
+64,300
+699% +$2.32M 0.01% 755
2022
Q3
$341K Buy
+9,200
New +$344K ﹤0.01% 1018
2022
Q2
Sell
-8,600
Closed -$442K 1188
2022
Q1
$442K Buy
+8,600
New +$368K ﹤0.01% 1055

Other funds holding PGNY

Axa's PGNY Position: Q2 2024 in Review

Axa sold out of Progyny (PGNY) in Q2 2024, closing a stake of 110,138 shares — an estimated $4.2M sold.

Axa first reported a position in PGNY in Q1 2022 and held it in 8 quarters. The position peaked at $4.2M in Q1 2024. 324 funds tracked by Wall St. Rank hold PGNY as of Q2 2024.

  • Axa reported no remaining Progyny position as of Q2 2024 after selling out during the quarter.
  • Axa sold 110,138 Progyny shares in Q2 2024, an estimated $4.2M.
  • Axa first reported a position in Progyny in Q1 2022 and held it in 8 quarters.
  • Axa's Progyny position peaked at $4.2M in Q1 2024.
  • 324 funds tracked by Wall St. Rank held Progyny as of Q2 2024.

Based on Axa's 13F filing for Q2 2024, filed 14 Aug 2024.